Company Filing History:
5 out of 1,152 
1 out of 151 
1 out of 16 
Years Active: 2012-2017
Title: Inventor Spotlight: Andrej Egorov
Introduction
Andrej Egorov, an accomplished inventor based in Vienna, Austria, has made significant contributions to the field of virology. With a total of 8 patents to his name, his work primarily focuses on innovative solutions for the influenza virus. His research aims to enhance vaccine formulations and provide new methodologies for combating viral infections.
Latest Patents
One of Andrej's notable latest patents is centered around a novel influenza virus that features modifications to both the NS and PB1 gene segments. This invention specifically includes the alteration of the PB1-F2 open reading frame by introducing at least one stop codon. The result is an influenza virus that lacks functional NS1 and PB1-F2 proteins, which can be used in vaccine formulations aimed at preventing influenza infections.
Another significant patent involves a replication-deficient influenza virus. This invention comprises a modified NS1 segment that codes for a NS1 protein devoid of a functional RNA binding domain and effector domain. Furthermore, a heterologous sequence is inserted between the splice donor site and splice acceptor site of the NS gene segment. This virus serves as a vector for expressing various proteins, such as chemokines, cytokines, or antigenic structures, and can be employed for vaccine production.
Career Highlights
Throughout his career, Andrej has been associated with prominent companies in the healthcare sector. He has worked at Baxter Healthcare and Baxalta GmbH, where he collaborated on advancing medical technologies and treatments, particularly in the field of infectious diseases.
Collaborations
Andrej has shared his professional journey with notable colleagues, including Markus Wolschek and Thomas Muster, fostering a collaborative environment that encourages the exchange of innovative ideas and research methodologies.
Conclusion
Andrej Egorov's work exemplifies the spirit of innovation within the realm of virology. Through his extensive research and patent filings, he continues to contribute to crucial advancements in vaccine development and infectious disease prevention. His inventive solutions pave the way for future discoveries and improvements in global health.